INPLASY202490012 Efficacy of Rituximab as Second-Line Therapy for Autoimmune Encephalitis: A systematic review and meta-analysis Keywords: rituximab, autoimmune encephalitis, treatment effects, N-methyl-D-aspartate receptor, Meta-analysis. Download PDF - 202490012 Review Status: completed but not published